Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
ZIVO

ZIVO - Zivo Bioscience, Inc. Stock Price, Fair Value and News

$20.96+0.30 (+1.45%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

ZIVO Price Action

Last 7 days

4.9%


Last 30 days

4.6%


Last 90 days

153.3%


Trailing 12 Months

1512.8%

ZIVO RSI Chart

ZIVO Valuation

Market Cap

74.3M

Price/Earnings (Trailing)

-5.43

Price/Sales (Trailing)

940.66

Price/Free Cashflow

-18.03

ZIVO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ZIVO Fundamentals

ZIVO Revenue

Revenue (TTM)

79.0K

Rev. Growth (Yr)

166.95%

Rev. Growth (Qtr)

-100%

ZIVO Earnings

Earnings (TTM)

-13.7M

Earnings Growth (Yr)

-24.31%

Earnings Growth (Qtr)

72.46%

ZIVO Profitability

Return on Equity

657.3%

Return on Assets

-2.8K%

Free Cashflow Yield

-5.55%

ZIVO Investor Care

Shares Dilution (1Y)

94.90%

ZIVO Alerts

  • 2 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202443.5K59.3K79.0K0
202300027.6K
20210000
20200000
20191.8M2.3M2.4M2.0M
20182.0M2.1M1.4M2.0M
20172.0M1.0M1.9M1.8M
20161.3M1.5M1.7M1.9M
20150001.1M
ZIVO
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
 CEO
 WEBSITEzivobioscience.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES8

Zivo Bioscience, Inc. Frequently Asked Questions


What is the ticker symbol for Zivo Bioscience, Inc.? What does ZIVO stand for in stocks?

ZIVO is the stock ticker symbol of Zivo Bioscience, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zivo Bioscience, Inc. (ZIVO)?

As of Tue Nov 19 2024, market cap of Zivo Bioscience, Inc. is 74.33 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZIVO stock?

You can check ZIVO's fair value in chart for subscribers.

Is Zivo Bioscience, Inc. a good stock to buy?

The fair value guage provides a quick view whether ZIVO is over valued or under valued. Whether Zivo Bioscience, Inc. is cheap or expensive depends on the assumptions which impact Zivo Bioscience, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZIVO.

What is Zivo Bioscience, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Nov 19 2024, ZIVO's PE ratio (Price to Earnings) is -5.43 and Price to Sales (PS) ratio is 940.66. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZIVO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zivo Bioscience, Inc.'s stock?

In the past 10 years, Zivo Bioscience, Inc. has provided 0.711 (multiply by 100 for percentage) rate of return.